Polypharmacy on first admission to hospital for people with heart failure: baseline findings from the PULSE cohort
Polypharmacy is common on first admission to hospital for people with heart failure. More medications at admission are associated with increasing age, co-morbidity, and frailty. People with polypharmacy are more likely to have a heart failure with preserved ejection fraction diagnosis, have worse symptoms and a longer hospital stay.
Authors
- Laura Pagès
- Adam Todd (ORCID: https://orcid.org/0000-0003-1496-9341)
- Andy Husband (ORCID: https://orcid.org/0000-0001-8162-8278)
- John Casement (ORCID: https://orcid.org/0000-0003-3514-7259)
- Andrew Kingston (ORCID: https://orcid.org/0000-0003-4211-7007)
- Janine Beezer (ORCID: https://orcid.org/0000-0001-7135-5886)
- Andrew L. Clark (ORCID: https://orcid.org/0000-0002-5213-9624)
Institutions
- Castle Hill Hospital (GB)
- Queen Elizabeth Hospital (GB)
- Sunderland Royal Hospital (GB)
- NIHR Newcastle Biomedical Research Centre (GB)
- South Tyneside and Sunderland NHS Foundation Trust (GB)
- Newcastle Hospitals - Campus for Ageing and Vitality (GB)
- Newcastle University (GB)
Publication Details
- Journal
- European Heart Journal - Quality of Care and Clinical Outcomes
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1093/ehjqcco/qcaf032
- Citations
- 1
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.22